Jin Seok Ahn

Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Solange Peters, D. Ross Camidge, Alice T. Shaw et al. · New England Journal of Medicine · 2017 · 2.4K citations · Full text

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Nayoung Kim, Hong Kwan Kim, Kyungjong Lee et al. · Nature Communications · 2020 · 1.3K citations · Full text

Metastatic Lung Adenocarcinoma, Immunology, Cancer Biology +20

Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

Tony Mok, D. Ross Camidge, Shirish M. Gadgeel et al. · Annals of Oncology · 2020 · 656 citations · Full text

Alectinib in Crizotinib-Refractory <i>ALK-</i>Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study

Sai‐Hong Ignatius Ou, Jin Seok Ahn, Luigi De Petris et al. · Journal of Clinical Oncology · 2015 · 578 citations

DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load

Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim et al. · Nature Communications · 2019 · 531 citations · Full text